ETON
Eton Pharmaceuticals Inc
54.80$
-0.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -55.7% | -739.0% | – | +135.2% | -125.9% | – | +280.8% | +51.1% | -196.1% | – | -2.0% | – | |
| – | +36.1% | -14.9% | +11.5% | +6.5% | +27.7% | +185.4% | -0.8% | +0.4% | +0.8% | +11.2% | +22.5% | – | |
| – | +2.7% | +9.5% | +2.3% | -14.0% | +8.3% | +53.5% | +74.7% | -47.9% | +2.9% | +35.1% | -3.3% | – | |
| – | +224.0% | -273.5% | – | -59.0% | -283.5% | – | – | +67.5% | -268.0% | – | -345.2% | – | |
| – | – | +142.8% | -100.0% | – | -99.4% | -100.0% | – | – | -82.7% | +53.1% | -93.3% | – | |
| – | – | +142.8% | – | – | -2,141.3% | – | – | – | -82.7% | +30,665.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -20.1% | +28.6% | -42.9% | +78.2% | – | -98.8% | -100.0% | – | – | +229.9% | -105.5% | – | |
| – | -235.3% | – | – | +147.1% | -307.4% | – | +220.4% | +47.5% | -195.2% | – | – | – | |
| – | -144.4% | – | – | +135.2% | -126.3% | – | +280.8% | +47.5% | -198.8% | – | -1.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.